FDA Import Refusal SCS-2664881-7/21/1 — Sangi Co.,Ltd.
The FDA refused shipment SCS-2664881-7/21/1 from Sangi Co.,Ltd. (Japan) on Dec 21, 2018. The refused product falls under Drugs and Biologics — CETYLPYRIDINIUM CHLORIDE (ANTI-INFECTIVE, TOPICAL). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Dec 21, 2018
- Country
- Japan
- Product Category
- Drugs and Biologics
- Product Code
- 62FBY07 CETYLPYRIDINIUM CHLORIDE (ANTI-INFECTIVE, TOPICAL)
- Charges
- 118,3280